The Use Of Brimonidine To Prevent Corneal Toxicity Caused By The Systemic Cancer Treatment Mirvetuximab Soravtansine.

Published 2023 - 41st Congress of the ESCRS

Reference: PO0760 | DOI: 10.82333/1wz8-r196